As of 4:00pm ET
| +0.05 / +1.47%|
The 4 analysts offering 12-month price forecasts for Opexa Therapeutics Inc have a median target of 11.00, with a high estimate of 18.00 and a low estimate of 6.00. The median estimate represents a +218.84% increase from the last price of 3.45.
The current consensus among 4 polled investment analysts is to Buy stock in Opexa Therapeutics Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.